[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
IJRR Information::
For Authors::
For Reviewers::
Subscription::
News & Events::
Web Mail::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
ISSN
Hard Copy 2322-3243
Online 2345-4229
..
Online Submission
Now you can send your articles to IJRR office using the article submission system.
..

AWT IMAGE

AWT IMAGE

:: Volume 24, Issue 2 (4-2026) ::
Int J Radiat Res 2026, 24(2): 397-403 Back to browse issues page
Evaluation of 68Ga-PSMA PET/CT in the staging of patients with prostate cancer
M.M.M. Shehata , H.A. Kader Morsy , R.S.E. Hussein , A.A.M. Okba
Department of Diagnostic Radiology, Faculty of Medicine, Ain Shams University, Cairo, Egypt , mahmoud.shehata007@gmail.com
Abstract:   (464 Views)
Background: Targeting prostate-specific membrane antigen (PSMA), with Gallium-68 PSMA-directed Positron Emission Tomography/Computed Tomography (68Ga-PSMA PET/CT) is advanced imaging technique for prostate cancer (PCa) diagnosis. The current study evaluated the performance of 68Ga-PSMA PET/CT for staging and follow-up of PCa patients. Material and Methods: 54 newly diagnosed (Group I) and 66 recurrent PCa patients (Group II) underwent estimation of serum total prostate-specific antigen (PSAT), calculation of PSA density (PSAD), and grading by the Gleason grading system. After obtaining the whole-body images using the integrated PET/CT scanner, Discovery IQ five-ring machine, and PET scanning, the maximum standardized uptake (SUV-max) values were calculated. Histopathology is the gold standard for assessment of the diagnostic performance of 68Ga-PSMA PET/CT for Group II. Results: The PSAT levels and density for Group I increased progressively with Gleason grade, with significant (P=0.021 and P=0.005, respectively) differences among grades. The lymph nodes and local tumor SUV-max were remarkably higher (P<0.001 & 0.01) in Group I. The SUV-max according to PSAT grades of Group I patients showed a significant (P<0.001) difference. There was positive, significant (P<0.001) relation between PSAD and SUV-max. The regression model for PSAD versus SUV-max was significant. The natural log of SUV-max increased by 2.03-fold with each fold increase in the natural log of PSAD. Conclusion: Integrating 68Ga-PSMA PET/CT in the diagnostic workup for PCa patients helps the management decision-making and is particularly valuable for lesions in areas inaccessible for biopsy, or if PSA levels are in the diagnostic gray-zone.
Keywords: Prostate cancer, prostate-specific membrane antigen, prostate-specific antigen density, 68Ga-PSMA PET/CT.
Full-Text [PDF 1009 kb]   (182 Downloads)    
Type of Study: Original Research | Subject: Radiation Biology
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shehata M, Kader Morsy H, Hussein R, Okba A. Evaluation of 68Ga-PSMA PET/CT in the staging of patients with prostate cancer. Int J Radiat Res 2026; 24 (2) :397-403
URL: http://ijrr.com/article-1-7018-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 24, Issue 2 (4-2026) Back to browse issues page
International Journal of Radiation Research
Persian site map - English site map - Created in 0.11 seconds with 50 queries by YEKTAWEB 4741